The United States Environmental Protection Agency (EPA) has taken a significant step towards addressing water quality concerns by proposing to classify microplastics and pharmaceuticals as contaminants in drinking water. This groundbreaking initiative, announced on 2 April 2026, marks the first time these substances have been included on the EPA’s Contaminant Candidate List, potentially paving the way for new regulations affecting water utilities across the country.
A Response to Public Concern
Lee Zeldin, the EPA administrator, underscored the urgency of this proposal, stating that it is a direct response to growing public anxiety about the safety of drinking water. “I can’t think of an issue that hits closer to home for American families than the safety of their drinking water,” Zeldin remarked during the announcement at the EPA headquarters in Washington DC. This move is seen as a win for health advocates, particularly those aligned with Robert F. Kennedy Jr.’s Maha movement, which has been actively campaigning for stronger regulations on environmental contaminants.
The proposed designation opens a 60-day comment period for the public, allowing citizens and stakeholders to voice their opinions before the EPA finalises the list, expected by mid-November. This development arrives at a time of heightened scrutiny regarding the presence of microplastics in various ecosystems and human health.
Understanding the Risks
Research has revealed increasing levels of microplastics not only in drinking water but also within human organs, including the heart and brain. While the exact implications for human health remain under investigation, experts indicate that these findings warrant concern. Additionally, pharmaceuticals often enter the water supply through human excretion, and conventional wastewater treatment facilities are frequently ill-equipped to eliminate these substances effectively.
The EPA’s Contaminant Candidate List serves as a crucial tool for prioritising research and regulatory actions, yet it has historically been slow to transition pollutants from consideration to regulation. Earlier this year, the agency indicated it would not develop regulations for any of the nine contaminants it reviewed in its last assessment, raising questions about the efficacy of this new initiative.
Advocates Call for Comprehensive Action
Despite some scepticism regarding the EPA’s track record, environmental advocates are cautiously optimistic about the proposed inclusion of microplastics on the Contaminant Candidate List. Judith Enck, a former EPA regional administrator and head of Beyond Plastics, called the proposal a promising first step towards eventual regulation of microplastics in public water supplies. “Hopefully, this is not the last step,” she asserted, urging for comprehensive measures to combat plastic pollution.
Dr. Philip Landrigan, director of the Global Observatory on Planetary Health at Boston College, echoed these sentiments, emphasising that regulatory progress must be accompanied by efforts to curb the escalating production of plastics, which is a fundamental driver of pollution. While the US participates in treaty discussions aimed at addressing global plastic pollution, it maintains a firm stance against restrictions on plastic production.
Political Dynamics and Future Implications
The synergy between Zeldin’s EPA and Kennedy’s Maha movement illustrates a unique political alignment focused on environmental health. This partnership emerges against a backdrop of frustrations over insufficient action on pressing issues, such as pesticide regulation and the broader implications of plastic pollution.
Kennedy’s recent announcement of a $144 million initiative, the Systematic Targeting of Microplastics (STOMP), aims to enhance detection and understanding of microplastics within the human body. “We can’t treat what we cannot measure. We cannot regulate what we don’t understand,” he stated, emphasising the need for scientific clarity before implementing effective regulations.
The Safe Drinking Water Act mandates the EPA to produce the Contaminant Candidate List every five years, requiring the assessment of at least five contaminants for potential regulation. However, the agency has frequently concluded that no regulatory action is necessary for the majority of contaminants reviewed in previous cycles. This has led to criticism from environmental groups who argue that the agency is not adequately protecting public health.
Why it Matters
The EPA’s proposal to designate microplastics and pharmaceuticals as contaminants in drinking water is a pivotal moment in the ongoing battle against environmental pollution. By acknowledging these substances’ presence in the water supply, the agency has opened the door to potential regulatory changes that could significantly impact public health and environmental policy. As public awareness of these issues rises, the effectiveness of the EPA’s actions will be closely scrutinised, with advocates pushing for robust measures to ensure safe drinking water for all Americans. The implications of this decision extend beyond the immediate concern of contaminants; it represents a critical juncture in the broader fight against plastic pollution, setting the tone for future environmental governance.
